Curis (CRIS) Treasury Shares (2010 - 2026)
Curis (CRIS) reported Treasury Shares of $1.5 million for Q4 2017, little changed on a YoY basis from $1.5 million in Q4 2016, and little changed quarter-over-quarter from $1.5 million in Q3 2017.
Curis (CRIS) Treasury Shares (2010 - 2026) Analysis & Trends
Curis has reported Treasury Shares for 8 years, with the latest figure at $1.5 million in Q4 2017.
- For the quarter ending Q4 2017, Treasury Shares changed 0.0% year-over-year to $1.5 million; the trailing twelve-month figure through Dec 2017 stood at $1.5 million (changed 0.0% YoY), and the FY2017 full-year result was $1.5 million, changed 0.0% from the prior year.
- Treasury Shares for Q4 2017 stood at $1.5 million, roughly flat from $1.5 million in the prior quarter.
- The five-year high for Treasury Shares was $263400.0 in Q3 2025, with the low at $40137.0 in Q2 2024.
- Historically, Treasury Shares has averaged $102479.8 across 4 years, with a median of $110500.0 in 2023.
- Annual changes were most pronounced in 2013 — Treasury Shares dropped 29.01% — and 2014, when it jumped 140.86%.
- Curis' Treasury Shares stood at $632755.0 in 2013, then jumped by 140.86% to $1.5 million in 2014, then decreased by 0.0% to $1.5 million in 2015, then changed by 0.0% to $1.5 million in 2016, then changed by 0.0% to $1.5 million in 2017.
- The last three Treasury Shares figures came in at $1.5 million (Q4 2017), $1.5 million (Q3 2017), and $1.5 million (Q2 2017), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | 1.48 Mn |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | 700,000.00 |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | - |
| 10 | Curis | 8.58 Mn | -6.42 Mn | - | 148,350.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 148,350.00 |
| Mar 31, 2026 | 148,350.00 |
| Sep 30, 2025 | 263,400.00 |
| Sep 30, 2025 | 263,400.00 |
| Mar 31, 2025 | 40,137.00 |
| Mar 31, 2025 | 40,137.00 |
| Dec 31, 2024 | 40,137.00 |
| Dec 31, 2024 | 40,137.00 |
| Sep 30, 2024 | 40,137.00 |
| Sep 30, 2024 | 40,137.00 |
| Jun 30, 2024 | 40,137.00 |
| Jun 30, 2024 | 40,137.00 |
| Mar 31, 2024 | 110,500.00 |
| Mar 31, 2024 | 110,500.00 |
| Dec 31, 2023 | 110,500.00 |
| Dec 31, 2023 | 110,500.00 |
| Sep 30, 2023 | 114,500.00 |
| Sep 30, 2023 | 114,500.00 |
| Jun 30, 2023 | 117,000.00 |
| Jun 30, 2023 | 117,000.00 |